Multidisciplinary Head and Neck Cancer Symposium in Phoenix

The Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM, will host two news briefings on top head and neck cancer research from its meeting February 25-27, 2010, in Phoenix.

What:Two audio news briefing from the Multidisciplinary Head and Neck Cancer Symposium. (Audio recordings and slides available after the news briefings on ASTRO's Web site (www.astro.org/pressroom/presskit).

When: Thursday, February 25, at 7:00 a.m. Mountain time (9:00 a.m. Eastern time)
Study findings previewed:
•Larynx preservation treatments result in low instance of severe voice disability, nutritional dysfunction.
•Proton therapy shows encouraging long-term outcomes for patients with locally-advanced sinonasal cancers.

How: Register for the webcast at https://astro.webex.com/astro/j.php?ED=119027472&RG=1&UID=0&RT=MiMxMQ%3D%3D. You will receive a confirmation e-mail with instructions for joining the meeting.

You may have the webcast call you directly or you may dial in to one of the numbers below.
*Call-in toll-free number (U.S./Canada): 1-866-699-3239
*Call-in toll number (U.S./Canada): 408-792-6300
*Access code: 686 481 081

When:Friday, February 26, at 7:00 a.m. Mountain time (9:00 a.m. Eastern time)
Study findings previewed:
•Pretreatment SUV associated with head and neck cancer treatment outcomes may help decided treatment plans.
•Concurrent accelerated radiation does not improve outcomes, lowers toxicity over standard radiation in head and neck cancer patients.

How: Register for the webcast at https://astro.webex.com/astro/j.php?ED=119027572&RG=1&UID=0&RT=MiMxMQ%3D%3D. You will receive a confirmation e-mail with instructions for joining the meeting.

You may have the webcast call you directly or you may call in to one of the numbers below.
*Call-in toll-free number (U.S./Canada): 1-866-699-3239
*Call-in toll number (U.S./Canada): 408-792-6300
*Access code: 681 490 414

Source:

AHNS

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
A faster, safer and more affordable technology to produce personalized cancer therapies